A detailed history of Prudential PLC transactions in Amgen Inc stock. As of the latest transaction made, Prudential PLC holds 68,776 shares of AMGN stock, worth $20.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
68,776
Previous 69,981 1.72%
Holding current value
$20.3 Million
Previous $21.9 Million 1.35%
% of portfolio
0.11%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $372,802 - $406,542
-1,205 Reduced 1.72%
68,776 $22.2 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $1.24 Million - $1.51 Million
4,729 Added 7.25%
69,981 $21.9 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $6.48 Million - $7.82 Million
24,109 Added 58.6%
65,252 $18.6 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $56,765 - $64,038
222 Added 0.54%
41,143 $11.9 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $823,654 - $1.02 Million
-3,767 Reduced 8.43%
40,921 $11 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2.63 Million - $3.11 Million
-12,259 Reduced 21.53%
44,688 $9.92 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $827,520 - $1.01 Million
3,665 Added 6.88%
56,947 $13.8 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $4.17 Million - $5.3 Million
18,217 Added 51.95%
53,282 $14 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $1.19 Million - $1.34 Million
5,305 Added 17.83%
35,065 $7.9 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1.25 Million - $1.39 Million
-5,399 Reduced 15.36%
29,760 $7.24 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $3.15 Million - $3.48 Million
-14,350 Reduced 28.98%
35,159 $8.5 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $2.49 Million - $2.85 Million
12,512 Added 33.82%
49,509 $11.1 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $6.06 Million - $7.1 Million
-28,535 Reduced 43.54%
36,997 $7.87 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $46.8 Million - $51.9 Million
-200,247 Reduced 75.34%
65,532 $16 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $5.15 Million - $6 Million
-23,213 Reduced 8.03%
265,779 $66.1 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $17 Million - $20.3 Million
-78,755 Reduced 21.42%
288,992 $66.4 Million
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $4.14 Million - $4.6 Million
17,647 Added 5.04%
367,747 $93.5 Million
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $29,671 - $36,411
-150 Reduced 0.04%
350,100 $82.6 Million
Q1 2020

May 01, 2020

SELL
$182.24 - $241.7 $36.4 Million - $48.3 Million
-199,638 Reduced 36.31%
350,250 $71 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $24.1 Million - $31 Million
-127,606 Reduced 18.84%
549,888 $133 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $39.9 Million - $47.8 Million
-228,903 Reduced 25.25%
677,494 $131 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $11.7 Million - $13.7 Million
70,273 Added 8.4%
906,397 $167 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $12.3 Million - $13.9 Million
-67,933 Reduced 7.51%
836,124 $159 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $12.3 Million - $14.3 Million
-68,720 Reduced 7.06%
904,057 $176 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $28.9 Million - $32.6 Million
-155,991 Reduced 13.82%
972,777 $202 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $1.77 Million - $1.98 Million
10,636 Added 0.95%
1,128,768 $208 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $2.93 Million - $3.42 Million
17,281 Added 1.57%
1,118,132 $191 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $15.9 Million - $17.7 Million
93,988 Added 9.33%
1,100,851 $191 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $6.01 Million - $6.86 Million
-35,905 Reduced 3.44%
1,006,863 $188 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,042,768
1,042,768 $180 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.